Secondary Logo

Editorial introductions

Section Editor(s): Keating, Armand; Spitalnik, Steven L.

Current Opinion in Hematology: November 2018 - Volume 25 - Issue 6 - p v–vi
doi: 10.1097/MOH.0000000000000468

Current Opinion in Hematology was launched in 1994. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of hematology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Editor and the Section Editors for this issue.

Back to Top | Article Outline


Armand Keating

Dr Keating is an internationally recognized leader in blood and marrow transplantation and cell therapy. He is a Professor of Medicine and of Biomedical Engineering and was the Director, Division of Hematology for almost two decades at the University of Toronto, Ontario, Canada and the first incumbent of the Epstein Chair in Cell Therapy and Transplantation. He established what has become the largest stem cell transplantation program in Canada at University Health Network, Toronto, Ontario, Canada and the Princess Margaret Cancer Centre, Ontario, Canada. He is a past president of the American Society of Hematology and also a past president of the American Society for Blood and Marrow Transplantation. He has served in a number of advisory roles at the US National Institutes of Health. Dr Keating is a co-founder of CellCAN, a consortium of cell manufacturing centres and their investigators across Canada and serves as chair of its Steering Committee. More recently, he has served as an advisor to the US New Organ Alliance and to NASA. His research and clinical interests focus on cell-based tissue regeneration, anti-cancer cell therapy, and blood and marrow transplantation. He has conducted laboratory, translational and clinical research in these areas, particularly on the biology and clinical application of mesenchymal stromal cells and NK cells.

Back to Top | Article Outline

Steven L. Spitalnik

Dr Spitalnik is currently the Executive Vice-Chair and has been a Professor in the Department of Pathology & Cell Biology at Columbia University, New York, USA since 2003. Previously, he was a faculty member in the Departments of Pathology & Laboratory Medicine at the University of Pennsylvania, Philadelphia, USA (1985–1998) and the University of Rochester, New York, USA (1998–2003).

He received his undergraduate education in mathematics at Princeton University, UK and his M.D. degree from the University of Chicago, Illinois, USA. His postgraduate work included residency training in anatomic and clinical pathology at the University of Rochester, and research fellowship training in molecular biology and in glycobiology at the University of Rochester and the National Institutes of Health, respectively.

Dr Spitalnik has held multiple committee and leadership positions in various organizations, such as the AABB, the Academy of Clinical Laboratory Physicians and Scientists, the American Society of Hematology, and the Council of Academic Societies.

Dr Spitalnik has published over 190 papers, edited two books, and has reviewed manuscripts for many journals, including serving on the Editorial Boards of Analytical Biochemistry, Transfusion, and Transfusion Medicine Reviews. In addition, he has served as a member and chair of multiple study sections at the National Institutes of Health and reviewed grant proposals for other domestic and international grant funding agencies.

Dr Spitalnik's research initially focused on glycobiology, particularly on the biosynthesis and immunology of glycoproteins and glycolipids, often using human blood group antigens as models (e.g. in the MNSs, ABH, P, and Lewis blood group systems). Over the last 15 years, he has used cell culture, mouse models, and studies in human volunteers and patient populations to investigate the consequences of red blood cell clearance in several settings, including following transfusions of refrigerator storage-damaged red blood cells, during hemolytic transfusion reactions, in G6PD-deficiency, and in malaria. His research is currently supported by grants from the National Institutes of Health.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.